[1] AHLFORS S R,STERNER O,HANSSON C. Reactivity of contact allergenic haptens to amino acid residues in a model carrier peptide,and characterization of formed peptide-hapten adducts[J]. Skin Pharmacol Appl Skin Physiol,2003,16:59-68. [2] APTULA A O,PATLEWICZ G,ROBERTS D W,et al. Nonenzymatic glutathione reactivity and in vitro toxicity:A non-animal approach to skin sensitization[J]. Toxicol In Vitro,2006,20:239-247. [3] DIVKOVIC M,PEASE C K,GERBERICK G F,et al. Hapten-protein binding:From theory to practical application in the in vitro prediction of skin sensitization[J]. Contact Derm, 2005,53:189-200. [4] KATO H,OKAMOTO M,YAMASHITA K,et al. Peptide-binding assessment using mass spectrometry as a new screening method for skin sensitization[J]. Toxicol Sci,2003,28,19-24. [5] GERBERICK G F,VASSALLO J D,BAILEY R E,et al. Development of a peptide reactivity assay for screening contact allergens[J]. Toxicol Sci,2004,81:332-343. [6] GERBERICK G F,VASSALLO J D,FOERTSCH L M,et al. Quantification of chemical peptide reactivity for screening contact allergens:a classification tree model approach[J]. Toxicol Sci,2007,97(2):417-427. [7] Organisation for Economic Co-operation and Development. Test No. 442C:In Chemico Skin Sensitization:Direct Peptide Reactivity Assay (DPRA)[S]. Paris:Organisation for Economic Co-operation and Development,2015. [8] 柯逸晖,陈彧,程树军,等. 直接多肽结合试验组合人细胞系活化试验预测皮肤致敏物的探讨[J]. 中国实验动物学报,2016,24(6):611-617. [9] 张劲松,桑晶,孙叶丹,等. 直接肽段结合方法在中药注射剂过敏反应预测中的应用[J]. 中国药品标准,2016,17(4):268-271. [10] 王滢,吴越. 皮肤致敏测试动物替代方法DPRA的建立和应用[J]. 日用化学工业,2017,47(2):90-95. [11] BOVERHOF D R,GOLLAPUDI B B,HOTCHKISS J A,et al. Evaluation of a toxicogenomic approach to the local lymph node assay (LLNA)[J]. Toxicol Sci,2009,107(2):427-439. [12] BASKETTER D A,BALIKIE L,DEARMAN R J,et al. Use of the local lymph node assay for the estimation of relative contact allergenic potency[J]. Contact Dermatitis,2000,42(6):344-348. [13] GERBERICK G F,RYAN C A,DEARMAN R J,et al. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals[J]. Methods, 2007,41(1):54-60. [14] HASEMAN J K,STRICKLAND J,ALLEN D,et al. Safety assessment of allergic contact dermatitis hazards:an analysis supporting reduced animal use for the murine local lymph node assay[J]. Regul Toxicol Pharmacol,2011,59(1):191-196. [15] LOVELESS S E,API A M,CREVEL R W,et al. Potency values from the local lymph node assay:application to classification,labelling and risk assessment[J]. Regul Toxicol Pharmacol,2010,56(1):54-66. [16] NUKADA Y,ASHIKAGA T,MIYAZAWA M,et al. Prediction of skin sensitization potency of chemicals by human Cell Line Activation Test (h-CLAT) and an attempt at classifying skin sensitization potency[J]. Toxicol in Vitro,26(2012) 1150-1160. [17] JOHANSSON H,ALBREKT A S,BORREBAECK C A K. The GARD assay for assessment of chemical skin sensitizers[J]. Toxicol in Vitro,2013,27:1163-1169. [18] BAUCH C,KOLLE S N,RAMIREZ T,et al. Putting the parts together:Combining in vitro methods to test for skin sensitizing potentials[J]. Regul Toxicol Pharmacol,2012,63:489-504. [19] RAMIREZ T,MEHLING A,KOLLE S N,et al. LuSens:A keratinocyte based ARE reporter gene assay for use in integrated testing strategies for skin sensitization hazard identification[J]. Toxicol in Vitro,2014,28:1482-1497. [20] NANDY A,KAR S,ROY K. Development and validation of regressionbased QSAR models for quantification of contributions of molecular fragments to skin sensitization potency of diverse organic chemicals[J]. SAR QSAR Environ Res, 2013,24(12):1009-1023. [21] DIVKOVIC M,PEASE C K,GERBERICK G F,et al. Hapten-protein binding:fromtheory to practical application in the in vitro prediction of skin sensitization[J]. Contact Dermatitis,2005,53(4):189-200. [22] GERBERICK G F,TROUTMAN J A,FOERTSCH L M,et al. Investigation of peptide reactivity of pro-hapten skin sensitizers using a peroxidase-peroxide oxidation system[J]. Toxicol Sci,2009,112:164-174. [23] TROUTMAN J A,FOERTSCH L M,KERN P S,et al. The incorporation of lysine into the peroxidase peptide reactivity assay for skin sensitizati on assessments[J]. Toxicol Sci,2011,122(2):422-436. [24] EC EURL-ECVAM (2013). Recommendation on the Direct Peptide Reactivity Assay (DPRA) for skin sensitisation testing[EB/OL]. (2013-12-12)http://ihcp.jrc.ec.europa.eu/our_labs/eurl-ecvam/eurl-ecvam-recommendations/eurl-ecvam-recommendation-on-the-direct-peptide-reactivity-assay-dpra. [25] NATSCH A,RYAN CA,FOERTSCH L,et al. A dataset on 145 chemicals tested in alternative assays for skin sensitization undergoing prevalidation[J]. J Appl Toxicol. 2013 Nov;33(11):1337-1352. [26] EC EURL ECVAM (2012). Direct Peptide Reactivity Assay (DPRA) Validation Study Report[EB/OL]. (2013-12-12) http://ihcp.jrc.ec.europa.eu/our_labs/eurl-ecvam/eurl-ecvam-recommendations/eurl-ecvam-recommendation-on-the-direct-peptide-reactivity-assay-dpra. |